You searched for "cancer"

1904 results found

What’s the appetite for clinical risk?

The first Professor and Chair of Medical Professionalism at RCSI and BSHS, Dubhfeasa Slattery provides an overview of how a desire for better healthcare at all levels can be harnessed and nourished, leading to a potential life-long interest in reducing...

Hearing care systems in Europe – can we do more?

52 million Europeans experience hearing loss but many don’t find their way to professional hearing care. Lidia Best looks at strategies to improve the uptake of amplification at a national level [1]. With rising numbers of people experiencing hearing loss,...

Fifth Sense James Lind Alliance Priority Setting Partnership for smell and taste disorders

Research priorities in the past have been dominated by the quixotic curiosity of individual academics and the capricious generosity of funding organisations. There must be a better way... At Fifth Sense, research is fundamental to the work we do. Above...

Why is a Raven like a writing desk? Some reflections on countertenors and castrati

The countertenor voice has seen a resurgence in popularity in the last 50 years. Nicholas Clapton is one of the foremost performers and teachers of his generation, and he tells us here about the link between countertenors and the (fortunately...

European funding for the tinnitus research network TINNET

Over 70 million people in Europe experience tinnitus, and for seven million it creates a debilitating condition. Severe tinnitus is often associated with depression, anxiety and insomnia, resulting in an enormous socio-economic impact [1]. It has been estimated that 13...

The doctor – pharmaceutical company relationship

‘Which drug rep is taking us out tonight?’ We have heard this phrase uttered at conferences since meetings began, but as Dylan said ‘those times they are a changing’ thanks to the Association of the British Pharmaceutical Industry (ABPI) and...

Leading and managing audiology service through a social enterprise model

As these things sometimes happen, our first conversations about Social Enterprise happened pretty much by chance and in our case were a by-product of discussions about a new department having outgrown the current one. The National Health Service (NHS) Audiology...

Validating a new international cholesteatoma classification – a necessary but challenging task

A European and Japanese joint consensus statement was published in 2017 which proposed a new cholesteatoma staging classification (EJS), with four stages. This follow-up publication aims to assess the internal and external validity of the staging system using existing prospectively...

What you need to know about recent advances in genetics of hearing loss in the newborn

Identifying the underlying genetic cause of hearing loss in newborns can improve dramatically the early diagnosis and appropriate intervention. Hearing loss is the most common sensory disorder at birth, affecting approximately two out of 1000 newborns [1]. Congenital impaired hearing...

In conversation with Miss Sujata De: Chair of the ESPO 2023 Local Programme Committee

Su De is one of the UK’s most prominent paediatric ORL surgeons, and has a leading role in planning ESPO 2023. Hannah Emerson caught up with Su recently to explore some of her thoughts and her plans for ESPO. You’ve...

In conversation with Shahed Quraishi

Professor Shahed Quraishi OBE. The ENT Masterclass® has been one of the most successful endeavours in ORL education and training in modern times. It has now been around for two decades. To mark the occasion and celebrate a coming of...

Composing with Meniere’s disease: a personal reflection

Is a fluctuating hearing loss and composing music incompatible? Professor Andrew Hugill discusses his personal experience of Meniere’s disease and the work that has developed as a result of the condition. As I write this article, I am in the...